FIIN-2|1633044-56-0|-陌孚医药/Medlife

您当前的位置：

FIIN-2

目录号: PL04812 纯度: ≥99%

CAS No. :1633044-56-0

商品编号	规格	价格	会员价
PL04812-5mg	5mg	¥1639.00	请登录
PL04812-10mg	10mg	¥2571.00	请登录
PL04812-25mg	25mg	¥5143.00	请登录
PL04812-50mg	50mg	¥8840.00	请登录
PL04812-100mg	100mg	询价	询价
PL04812-200mg	200mg	询价	询价
PL04812-10mM*1mLinDMSO	10mM*1mLinDMSO	¥2288.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	FIIN-2
中文别名	FIIN-2
英文名称	FIIN-2
英文别名	FIIN-2;N-(4-((3-(3,5-Dimethoxyphenyl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)methyl)phenyl)acrylamide;FIIN2;BCP14779;BDBM50232829;s7714;A12357;N-(4-{[3-(3,5-dimethoxyphenyl)-7-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-oxo-1H,2H,3H,4H-[1,3]diazino[4,5-d]pyrimidin-1-yl]methyl}phenyl)prop-2-enamide;N-[4-[[3-(3,5-Dimethoxyphenyl)-7-[4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimid
Cas No.	1633044-56-0
分子式	C₃₅H₃₈N₈O₄
分子量	634.73
包装储存	Powder -20°C 3 years；4°C 2 years

产品详情	FIIN-2 是 FGFR 的不可逆抑制剂，对FGFR1，FGFR2，FGFR3和FGFR4的IC₅₀ 值分别为3.1，4.3，27和45 nM。
生物活性	FIIN-2 is an irreversible inhibitor of FGFR with an IC 50 of 3.1, 4.3, 27, and 45 nM for FGFR1, FGFR2, FGFR3 and FGFR4, respectively.
性状	Solid
IC50 & Target[1][2]	FGFR1 3.1 nM (IC50) FGFR2 4.3 nM (IC5
体外研究(In Vitro)	FIIN-2 potently inhibits WT FGFRs (EC50s in the 1- to 93-nM range) and the gatekeeper mutant of FGFR2 (EC50 of 58 nM). FIIN-2 also moderately inhibits EGFR, with an IC50 of 204 nM. FIIN-2 inhibits proliferation of FGFR1-4 Ba/F3 cells with EC50s in the single- to double-digit nanomolar range and are especially potent against FGFR2, with EC50s in the 1-nM range. FIIN-2 shows good potency against gatekeeper mutant V564F. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)	Treatment of fish in the embryonic state with either FIIN-2 causes defects to the posterior mesoderm similar to the phenotypes reported following genetic knockdown of FGFR or treatment with other reported FGFR inhibitors. FIIN-2 causes mild or severe phenotypes to the tail morphogenesis in all treated embryonic zebrafish. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Powder -20°C 3 years；4°C 2 years
参考文献	[1]. Tan L, et al. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors. Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):E4869-4877.

溶解度数据	In Vitro: DMSO : ≥ 30 mg/mL (47.26 mM)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation